iShares Biotechnology ETF $IBB Stake Lessened by FRG Family Wealth Advisors LLC

FRG Family Wealth Advisors LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 13.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,459 shares of the financial services provider’s stock after selling 3,338 shares during the period. FRG Family Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,622,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. BNP Paribas Financial Markets lifted its stake in iShares Biotechnology ETF by 313.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after acquiring an additional 1,451,820 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in iShares Biotechnology ETF by 27.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after acquiring an additional 226,852 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $65,083,000. Barclays PLC lifted its stake in iShares Biotechnology ETF by 6.7% in the 3rd quarter. Barclays PLC now owns 416,191 shares of the financial services provider’s stock worth $60,085,000 after acquiring an additional 26,032 shares in the last quarter. Finally, Focus Partners Wealth lifted its stake in iShares Biotechnology ETF by 8.8% in the 3rd quarter. Focus Partners Wealth now owns 116,844 shares of the financial services provider’s stock worth $16,878,000 after acquiring an additional 9,404 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $168.50 on Wednesday. The stock has a 50-day moving average price of $170.28 and a 200 day moving average price of $165.67. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.